These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 29655578

  • 21. Cholesterosis following chemoreduction for advanced retinoblastoma.
    Gombos DS, Howes E, O'Brien JM.
    Arch Ophthalmol; 2000 Mar; 118(3):440-1. PubMed ID: 10721978
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Trans Am Ophthalmol Soc; 2004 Mar; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. New Strategies in the Treatment of Unilateral Sporadic Retinoblastoma.
    Shields CL, Shields JA.
    J Pediatr Ophthalmol Strabismus; 2015 Mar; 52(3):134-7. PubMed ID: 26053204
    [No Abstract] [Full Text] [Related]

  • 29. A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma.
    Chronopoulos A, Babst N, Schiemenz C, Schutz JS, Heindl LM, Ranjbar M, Kakkassery V.
    Neurosignals; 2022 Nov 11; 30(S1):39-58. PubMed ID: 36354963
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment modalities and results of comprehensive therapy for extended retinoblastoma in children].
    Belkina BM, Durnov LA, Poliakov VG, Goldobenko GV, Glekov IV, Ushakova TL.
    Vopr Onkol; 1997 Nov 11; 43(4):435-9. PubMed ID: 9381699
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. White orbital mass after enucleation for retinoblastoma: The power of illusion.
    Soliman SE, Halliday W, Shaikh F, Chan H, Hèon E, Gallie BL.
    Ophthalmic Genet; 2017 Dec 11; 38(6):584-586. PubMed ID: 28306364
    [No Abstract] [Full Text] [Related]

  • 36. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, Lévy-Gabriel C, Brisse HJ, Desjardins L, Doz F.
    J Clin Oncol; 2013 Apr 10; 31(11):1458-63. PubMed ID: 23460706
    [Abstract] [Full Text] [Related]

  • 37. Emerging chemotherapeutic strategies in the management of intraocular retinoblastoma.
    Bhisitkul RB, Mukai S.
    Int Ophthalmol Clin; 1997 Apr 10; 37(4):201-14. PubMed ID: 9429942
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Update on intra-arterial chemotherapy for retinoblastoma.
    Zanaty M, Barros G, Chalouhi N, Starke RM, Manasseh P, Tjoumakaris SI, Shields CL, Hasan D, Bulsara K, Rosenwasser RH, Jabbour P.
    ScientificWorldJournal; 2014 Apr 10; 2014():869604. PubMed ID: 25405236
    [Abstract] [Full Text] [Related]

  • 40. Exposure of primary orbital implants in postenucleation retinoblastoma patients.
    Lee V, Subak-Sharpe I, Hungerford JL, Davies NP, Logani S.
    Ophthalmology; 2000 May 10; 107(5):940-5; discussion 946. PubMed ID: 10811087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.